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Evaluation of pressure transmission and
intra-aneurysmal contents after endovascular
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Objective: Endotension has been defined as persistently increased pressure within the excluded sac of an abdominal aortic
aneurysm (AAA) resulting in increasing aneurysm size after endovascular repair in the absence of endoleak. Devices that
use expanded polytetrafluoroethylene (ePTFE) have been associated with the development of endotension and continued
AAA enlargement. In this study, intra-aneurysmal pressure and aneurysm content were evaluated after endovascular
repair with the Enovus ePTFE stent graft in a canine model.
Methods: Prosthetic ePTFE aneurysms, each containing a solid-state, strain-gauge pressure transducer, were implanted in
the infrarenal aorta of 13 mongrel dogs (25-35 kg). A second pressure transducer was inserted into the native aorta for
systemic arterial pressure measurement. The stent graft was then deployed to exclude the aneurysm via distal aortic access.
Comparison was made among three distinct stent grafts: the Trivascular Enovus (nonporous ePTFE; four animals), the
original Gore Excluder (porous ePTFE; five animals), and the Medtronic AneuRx (Dacron; four animals). Daily systemic
and intra-AAA pressures were measured for 4 weeks. Intra-aneurysmal pressures were indexed to simultaneously
measured systemic pressures. After 4 weeks, the aorta, the prosthetic aneurysm, and its contents were harvested,
photographed, and processed for histologic investigation with hematoxylin and eosin and Masson trichrome staining.
Results:Within 24 hours after exclusion, the mean arterial pressure and pulse pressure within the AAA sac tapered to less
than 20% of systemic pressure for all three stent graft types. Throughout the postoperative period, significantly lower
indexed intra-aneurysmal pressures were present in the Enovus- and AneuRx-treated aneurysms as compared with those
treated with the original Excluder stent graft (0.05 0.04, 0.16 0.06, and 0.06 0.03 for the Enovus, Excluder, and
AneuRx, respectively). Histologic analysis of the Enovus-treated aneurysms demonstrated intraluminal content charac-
terized almost entirely by erythrocytes and infrequent white blood cells without the fibrin organization—characteristics
of acute or chronic thrombus. This contrasted with the content of the Excluder-treated aneurysms, which contained
poorly organized fibrin deposition suggestive of acute thrombus, and of the AneuRx-treated aneurysms, which
demonstrated mature, well-organized collagenous connective tissue.
Conclusions: Exclusion of the AAA with the Enovus stent graft resulted in nearly complete elimination of intra-
aneurysmal pressure in this model. Histologic analysis of the aneurysm content further suggested complete exclusion,
including elimination of circulating clotting factors and fibroblasts responsible for thrombus formation and reorgani-
zation. Ultimately, clinical evaluation will be necessary to demonstrate the effectiveness of this stent graft in preventing
the development of endotension. (J Vasc Surg 2007;46:1005-13.)
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November 20071006 Hynecek et alClinical Relevance: Endovascular aneurysm repair is an effective method for the treatment of abdominal aortic aneurysm
(AAA) subjected to the unique complications of endoleak and endotension, the indirect pressurization of a sac in the
absence of endoleak. In our model, AAA exclusion with the Enovus stent graft results in inhibition of fluid and serum
transudation into the AAA sac, a corresponding prompt pressure decay profile, and near-complete elimination of
intra-aneurysmal pressure. With the advent of implantable wireless pressure transducers, this research can be readily
translated to the clinical setting. Future intraoperative and postoperative studies may help elucidate the clinical
significance of pressure decay profiles in identifying successful AAA exclusion and monitoring for the development of
endotension and its clinical sequelae.Although endovascular aneurysm repair (EVAR) is an
effective method for the treatment of abdominal aortic
aneurysm (AAA), a set of complications that are distinct
from those encountered during open repair can compro-
mise long-term outcome.1-3 Endoleak, the direct commu-
nication of the systemic circulation with the excluded an-
eurysm sac, and endotension, the indirect pressurization of
sac in the absence of endoleak, are complications specific to
EVAR.4,5 Attachment site endoleaks can be mitigated with
careful preoperative planning, meticulous aneurysm mea-
surement, and appropriate stent graft selection. Endoten-
sion, however, may be attributed in part to limitations in
the graft material or in the stent-graft design.4-8
Graft material separates the intravascular space from the
aneurysm sac to reduce the transmission of pressure to the
aneurysm wall. The durability of the repair relies on bio-
compatible material suitable for use as a vascular graft.
Expanded polytetrafluoroethylene (ePTFE) exhibits desir-
able characteristics as a vascular graft because it is biologi-
cally inert and can be used to construct low-profile endo-
vascular devices. However, it has been postulated that the
transfer of fluid blood components through the porous
ePTFE graft can contribute to endotension in the absence
of a documented endoleak and ultimately lead to pressur-
ization and expansion of the aneurysm sac. Consequently,
the occurrence of endotension in stent grafts constructed
with porous ePTFE has led to the modification of these
devices.4,8-10 The recent introduction of a low-permeability
ePTFE material may reduce the likelihood of this specific
complication without compromising device profile or graft
durability.11,12
Fig 1. A photograph of a deployed Enovus stent gr
permeability expanded polytetrafluoroethylene graft bod
stents (BS), with a covered stent (CS) component locate
with epoxy during graft deployment.In this study, characteristics and behavior of low-
permeability ePTFE graft material were compared with
those of porous ePTFE and Dacron stent grafts (DuPont,
Wilmington, Del) by using a canine model. Intra-aneurys-
mal pressure and aneurysm sac contents were evaluated
after EVAR with three distinct stent grafts. This model has
been used to investigate implantable pressure sensors and
type II endoleaks.10,13-15 The aims of this study were to
evaluate intra-aneurysmal pressure after exclusion with the
Enovus stent graft, to characterize the intra-aneurysmal
content and graft histologically, and to compare it with
Food and Drug Administration–approved stent grafts.
METHODS
Overview. A caninemodel of AAAwas used to analyze
pressure transduction across graft material in three unique
devices by measuring the pressure within prosthetic aneu-
rysm sacs implanted as interposition grafts within the infra-
renal canine aorta. Each animal was implanted with a pros-
thetic aneurysm sac and a single stent graft. Thirteen dogs
were separated into three groups to evaluate the Enovus
(Trivascular, SanDiego, Calif; four animals), Excluder (WL
Gore & Associates, Flagstaff, Ariz; five animals), and
AneuRx (Medtronic,Minneapolis, Minn; four animals). All
animals were treated in accordance with the Guide for the
Care and Use of Laboratory Animals.16
Stent grafts. The stent grafts used in this study each
incorporate unique design elements and materials within
their construction. The Trivascular Enovus (Fig 1) uses
barbed nitinol stents, which are isolated to the proximal
and distal ends of the stent graft. The body of the graft is
ighlights characteristics of its construction. The low-
) is bounded on either extremity by barbed nitinol bare
re proximally. A series of circular channels (*) are filledaft h
y (GB
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and low-permeability ePTFE material. A series of ring-
shaped cavities are incorporated into the body of the graft
and are filled at the time of deployment with a radiopaque,
three-component epoxy that solidifies to create a rigid
scaffold. The covered portion is 6 cm, with a total length of
9 cm, and the lumen diameter is 10 mm. The remaining
two grafts embrace a more traditional design, with graft
material that extends along the entire length of the device.
The first-generation Gore Excluder is composed of in-
creased-permeability ePTFE. After this study, the Excluder
was upgraded to include an ePTFE material that is lami-
nated with a low-permeability film and an ePTFE-reinforc-
ing film.11 The outer diameter of the graft is 12 mm, with
a length of 7 cm. The latest-generation Medtronic AneuRx
uses a low-porosity polyethylene terephthalate (Dacron)
fabric, which is hydrophilic and is rapidly incorporated into
surrounding tissue. This graft also has an outer diameter of
12 mm, with a length of 5.5 cm.17-19 All three graft types
are inserted into the aorta through a 12F introducer sheath
or delivery system.
AAA creation. Prosthetic implantable aneurysm sacs
were created before surgery by using a single 10-cm-long
segment of an 8-mm thin-walled PTFE vascular graft (Bard
Fig 2. Intraoperative photographs are oriented with th
abdominal aorta is exposed from the renal arteries to t
intraluminal transducer (T) is placed as an interposition
visible adjacent to the abdominal aorta.Medical, Covington, Ga). The 8-mm PTFE was dilated byusing a 30-mm noncompliant angioplasty balloon to pro-
duce a final spherical aneurysm 30 mm in diameter. A
solid-state pressure transducer was secured to the aneurysm
wall with a 5-0 polypropylene suture before ethylene diox-
ide gas sterilization.
AAA implantation and AAA exclusion procedure.
Dogs were loaded with 225 mg of clopidogrel before
surgery. An intramuscular injection of tiletamine hydro-
chloride (2.2 mg/kg), zolazepam hydrochloride (2.2 mg/
kg), xylazine hydrochloride (2.2 mg/kg), and atropine
sulfate (0.2 mg/kg) was administered. The animals were
intubated, and general anesthesia was maintained with
inhaled isoflurane. A midline abdominal incision was made,
and the viscera were displaced cranially to expose the ret-
roperitoneum. The aorta was dissected circumferentially
between the renal arteries and the aortic trifurcation (Fig
2). Infrarenal aortas measured 9 mm in diameter midway
between the renal arteries and trifurcation. Intraoperative
anticoagulation was maintained by using intravenous un-
fractionated heparin sodium (2000-U bolus followed by a
500 U/h infusion). The infrarenal aorta was exposed,
clamped proximally and distally, and then transected. The
prosthetic aneurysm was implanted by using a 5-0 proline
suture to create each end-to-end anastomosis (Fig 2). Next,
ximal aorta on the left of the image. A, The infrarenal
furcation. B, The prosthetic aneurysm (AAA) with an
in the infrarenal aorta. The inferior vena cava (IVC) ise pro
he tri
graftflowwas re-established, and intraoperative angiography was
JOURNAL OF VASCULAR SURGERY
November 20071008 Hynecek et alused to confirm the patency of the aneurysm sac (Fig 3). The
stent graft was introduced through the native aorta distal to
the AAA to allow appropriate space for a distal landing
zone. The aneurysm was then excluded by deployment of
the endograft, and completion angiography was performed
to document successful exclusion. Finally, a second solid-
state pressure transducer was introduced through the aor-
totomy and secured with 5-0 proline sutures. Cables from
the systemic and intra-aneurysmal transducers were tun-
neled dorsolaterally through the abdominal wall and then
subcutaneously to exit the skin at the interscapular space.
The abdominal incision was closed in three layers, and the
transducer interface was secured with absorbable suture.
Pressure sensor system. Two X6 series solid-state
strain-gauge transducers (Konigsberg; Triton Technology
Inc, San Diego, Calif) were implanted into each animal for
the independent collection of systemic and aneurysm sac
pressures. The sensors were secured within the lumen of the
vessel and connected by a silicone-insulated cable to a
skin-level interface. This interface was designed to allow
ingrowth of dermis, to minimize infection, and to secure
the interface for long-term follow-up monitoring. Each
transducer had a designated compensation module, which
was connected in tandem through a cable to a central
processing unit for data collection.
Pressure collection. CA Recorder software (version
Fig 3. A, Intraoperative angiography illustrates the pro
Component epoxy can be visualized as radiopaque rings,
the proximal and distal nitinol stents. C, Completion a
endoleak.2.00; Data Integrated Scientific Systems, Dexter, Mich)was used to acquire all pressure data. Immediately after
implantation of the prosthetic aneurysm sac, intraoperative
pressure data collection commenced via the transducer
implanted within the sac. Data collection continued
throughout the duration of the procedure, and events
pertaining to the deployment of the graft were documented
and referenced to the pressure tracing. During the postop-
erative period, pressure data were collected from both sac
and systemic transducers in each animal. Each sequence of
data points was collected at intervals of 10 seconds for 5
minutes each day for 30 days. Data points collected during
and after surgery included systolic blood pressure, diastolic
blood pressure, mean arterial pressure (MAP), pulse pres-
sure, and heart rate.
Radiographic confirmation of graft placement.
Computed tomography (CT) angiography with general anes-
thesiawas performedduring the secondpostoperativeweek to
confirm exclusion of the aneurysm sac from the arterial circu-
lation. A localizer image was acquired, and the region of
interest was identified. A 40-mL bolus of iohexol (300 mg/
mL) contrast agent was injected intravenously at 3 mL/s
immediately before imaging, and an image serieswas collected
from the abdominal region of interest by using aDiscovery ST
CT scanner (General Electric, Piscataway, NJ).
Euthanasia and thrombus evaluation. After the
completion of postoperative pressure data collection, each
c aneurysm (AAA) and incorporated transducer (T). B,
h demarcate the body of the Enovus graft (SG) between
raphy confirms aneurysm exclusion and the absence ofstheti
whic
ngiogdog was killed by using a lethal injection of pentobarbital.
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ing pressure transducers were carefully removed. The aneu-
rysm was divided longitudinally, and the stent graft was re-
moved from the lumen and inspected for integrity (Fig 4).
Representative cross-sections of the aorta and aneurysm sac
were collected and fixed in a 10% buffered formalin solution.
Sections of the tissue samples were mounted and stained by
using hematoxylin and eosin and Masson trichrome.
Statistical analysis. Unpaired Student t tests were
performed by using SPSS version 15.0 for Windows (SPSS,
Chicago, Ill). All values are represented as mean SD, and
P  .05 was considered statistically significant.
RESULTS
Intraoperative pressure measurement. Continuous
intraoperative pressure collection enabled the identification
of pulse pressure elimination and the characterization of
mean pressure decay within the excluded aneurysm sac (Fig
5). Pulse pressure exhibited an abrupt elimination of signal
in all animal groups, and this coincided with the complete
deployment of the endovascular stent graft. Fleeting inter-
mittent pulse pressure signals appeared during the postex-
clusion period with no more than four episodes per animal,
comprising 0.984%  0.891% of the total postdeployment
intraoperative measurement time. In contrast to the pulse
pressure, MAP measured from within the aneurysm sac
initially persisted in each group and then subsequently
dissipated. In the Enovus group, MAP decay commenced
Fig 4. Once explanted, the prosthetic aneurysm sac wa
separated from the aorta to evaluate aneurysm sac conten
each end-to-end anastomosis (A) connecting the prosth
the stent graft to the native arterial wall can be demonstra
surface of the aorta (*).abruptly and had consistent dissipation characteristics in allanimals tested. Pressure decay events were aligned so that
the steepest slope and asymptote from each plot coincided.
The regression analysis of aneurysm sac pressure decay
followed the exponential function Pt  Poe
0.0271t, where
t  time in seconds (Fig 6). The pressure half-life equaled
256 seconds, with a coefficient of determination (R2) equal
to 0.989 for the mean pressure decay interval of 20 min-
utes. Mean pressure dissipation plots in the Excluder and
AneuRx animal groups were gradual, and the profiles were
not as highly conserved as in the Enovus group.
Postoperative pressure measurement. Pressure data
were collected from both sac and systemic transducers in
each animal during the postoperative period. Indexed val-
ues were calculated by comparing each sac pressure mea-
surement to the systemic pressure measurement, and the
means of each group were compared. Indexed sac pressure
from the Enovus group was significantly lower than sac
pressure associated with the first-generation Excluder (Ta-
ble; P .01). No significant difference was found between
indexed pressures in the Enovus and AneuRx groups (Ta-
ble; P .08). Additionally, in the three stent-graft groups,
the AAA sac pressure decreased to the mean value repre-
sented in the Table within the first postoperative day. Each
long-term pressure profile was horizontal for the duration
of the 30-day postoperative period. Linear regression
curves fitted to each plot confirmed no significant differ-
ence in slope between animal groups (not significant).
CT angiogram. Surveillance CT angiography demon-
ded longitudinally, and the Enovus stent graft (SG) was
) and aid in visualization of the graft. Suture lines reveal
neurysm sac to the native aorta. Excellent apposition of
y the impression left by the covered stent on the luminals divi
ts (SC
etic a
ted bstrated that each graft was patent, and no endoleaks were
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period. Figure 7 represents a contrast-enhanced CT angio-
gram of an excluded AAA sac.
Histologic analysis. Postmortem evaluations consis-
tently demonstrated that prosthetic aneurysms were well
incorporated into the retroperitoneum and that dense fi-
brous connective tissue was adherent to the PTFE with no
evidence of fluid collection outside of the aneurysm. His-
tologic evaluation also demonstrated notable differences
within the aneurysm sacs in the three experimental groups.
Within sacs excluded by the Enovus, the luminal contents
were characterized almost entirely by erythrocytes, with few
scattered white blood cells, occasional engorged hemo-
siderophages, rare amounts of eosinophilic fibrin, and nu-
merous inflammatory cells (Fig 8). The lack of organization
or lamination of sac contents suggested the absence of
acute or chronic aneurysmal thrombus. Within prosthetic
Fig 5. Mean arterial pressure (MAP; black) and pulse p
transducer located in the aneurysm sac. After the insertion
extinguished, but MAP persisted. Pulse pressure artifacts
Epoxy was injected to solidify the stent between interval
balloon fixation of the distal and proximal stents (D a
abdominal closure (F).
Fig 6. A highly conserved pattern of exponential mean arterial
pressure decay was witnessed only in aneurysm sacs excluded with
the Enovus stent graft. An exponential regression for the 20-
minute mean pressure decay interval has a coefficient of determi-
nation (R2) equal to 0.989.AAA sacs excluded with the Dacron AneuRx device, ma-ture, trichrome-positive collagenous connective tissue
densely covered the aneurysm and graft surfaces within the
prosthetic AAA sac. Small blood vessels were visible within
the organized focus of connective tissue. Granulation tissue
was adjacent to the collagenous loci. Consistent with orga-
nized thrombus, abundant disorganized eosinophilic fibrin
and abundant erythrocytes formed an acute thrombus ad-
jacent to the collagenous and granulation tissue. Aneurysm
sac contents in the Excluder group had an appearance
analogous to an acute fibrin thrombus. Fibrin was arranged
between the prosthetic aneurysm and the stent, and a few
neovessels traversed the fibrin thrombus.
DISCUSSION
The prosthetic aneurysm model of AAA is a useful tool
for the in vivo investigation of stent graft permeability and
aneurysm sac pressure characteristics. The dilated segment
of PTFE used in the creation of the prosthetic AAA pro-
vides an acceptable hemodynamic reproduction of an AAA.
Reliable consistencies in aneurysm size, shape, and volume
ensure the accurate measurement of pressure in fluid or
thrombus from within the aneurysm sac during postopera-
tive measurements.13,20,21 Histologic phenomena ob-
served within the AAA sac assist in the description of the
interactions between the stent graft and circulating
blood.21
The AneuRx and Excluder devices have been used
extensively in clinical practice. Use of the Enovus stent graft
has been limited to a phase I Food and Drug Administra-
tion trial, and it is the primary focus of this study. The
Enovus has an outer diameter of 10 mm (11.1% oversized),
and the AneuRx and Excluder devices are 12 mm in diam-
eter (33.3% oversized). Distal stent graft migration is the
most frequently cited complication in AAAs repaired with
grafts oversized by greater than 30%.22 There was no
incidence of stent graft migration, endoleak, AAA rupture,
re (gray) tracings were collected during surgery from a
and deployment (B) of the stent graft, pulse pressure was
e seen as intermittent spikes throughout the procedure.
d C. Inconsistency in the MAP signal is evident during




nd E)or stent graft occlusion in this study. The most striking
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reinforce the flexible graft. The epoxy transforms a flexible
graft into a rigid conduit through a low-profile delivery
system. Permeability is unlikely to be affected by the epoxy
filling material because it hardens into a widely fenestrated
supportive structure. Rather, the reduced permeability of
the Enovus at physiologic pressure gradients is conferred by
the incorporation of additional coatings to the ePTFE graft
material.23,24
Expanding AAA sacs without CT evidence of endoleak
contain a gelatinous material likely composed of a plasma
ultrafiltrate. This phenomenon, known as a sac hygroma,
has been primarily described in AAAs excluded with ePTFE
stent grafts and is a purported cause of endotension. Pros-
thetic aneurysm sacs explanted from dogs in this study did
not contain hygromas. Each animal was investigated for a
period that did not exceed 30 days; thus, the time for
postoperative hygroma development may have been lim-
Table. Pressure and histologic data
Group Stent graft Materi
I Trivascular Enovus ePTFE
II Gore Excluder ePTFE
III Medtronic AneuRx Dacron
I vs II‡ — —
I vs III — —
II vs III — —
ePTFE, Expanded polytetrafluoroethylene.
*Mean intra-aneurysmal pressure indexed to systemic mean arterial pressur
†Trivascular Enovus uses low-permeability ePTFE.
‡Mean pressure comparison using unpaired Student t tests.
Fig 7. Surveillance computed tomographic angiograms were
conducted during the postoperative period to evaluate stent-graft
position and search for evidence of endoleak. A representative axial
image demonstrates intravenous contrast within the stent graft
(SG) without radiologic evidence of leak into the aneurysm sac
(AAA). Radiodensity ventral to the AAA represents the transducer
cable (T).ited. With the Enovus graft, no evidence of transudation ofserous components was detected, so hygroma formation in
this group was unlikely.
The physical and functional characteristics of the graft
materials are critical to understanding the potential for
AAA sac hygroma formation and for subsequent endoten-
sion. Internodal distance and porosity represent the physi-
cal characteristics of the individual materials within the
stent grafts. Expanded PTFE is typified by solid nodes of
PTFE connected by tendrils that span the internodal space.
The distance between the nodes (internodal distance) de-
fines the porosity. Permeability is the functional character-
istic classified by the ability of a material to transmit fluids
and is a directly measured value. Water entry pressure, the
pressure threshold that must be overcome to push water
through a material, is an industry metric used for the
permeability of ePTFE. The water entry pressures of the
ePTFE devices used in this study are proprietary, thus
requiring us to infer the degree of permeability by pressure
decay curve analysis. Dacron can also be described by its
porosity, but it is more accurately described by its perme-
ability. Untreated Dacron grafts rely on fibrin deposition
within the interstices of the fabric before an effective fluid
barrier can be formed. The permeability of Dacron grafts
used in this study10 was 211  26 mL · min1 · cm2.
Immediately after the deployment of the Enovus graft,
the pulse pressure was eliminated, and the mean pressure
followed a precipitous decay. This finding is likely linked to
the relative impermeability of the ePTFE material in the
Enovus. In AAAs excluded with the AneuRx, sac pressure is
maintained throughout the intraoperative period, and this
agrees with the relatively high permeability of the Dacron
graft. Measurements taken at the first postoperative day,
however, demonstrate pressure elimination.
As described, the graft material within the Excluder has
been improved to include a low-permeability film and a
reinforcing film. At the time that this study was initiated,
the original Gore Excluder graft was available but has since
become unavailable. New clinical data regarding the per-
formance of the modified Excluder have emerged, but no
long-term studies evaluating the efficacy of the graft are
available. AAA sac pressure characteristics across the new
Excluder stent graft using an in vivo animal model have not
Indexed mean
pressure* Histologic findings
0.05  0.04 No thrombus
0.16  0.06 Acute thrombus
0.06  0.03 Organized thrombus
P  .01 —
P  .08 —
P  .04 —
sented with standard deviation.al
†
e repreyet been published.11
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based on the principle that the mechanism of endotension
is pressurization of an AAA without evidence of endoleak.
The transducers used in this experiment are sensitive and
can detect abrupt changes or even slight trends in pressure
over limited periods of time.21 The capability to detect
these changes in this model has provided a method to
identify endotension before conventional imaging can
identify changes in AAA diameter. The long-term conse-
quences of endotension, however, are incompletely charac-
terized. The breadth of this study has been intended to
correlate sac pressure with graft performance and does not
attempt to associate long-term sac pressurization with com-
plications of EVAR. Repressurization of the AAA sac com-
promises fixation zones via continued expansion and dis-
tortion of the AAA.25
Complete elimination of pulse pressure was seen with
all grafts investigated in this study. An intermittent pulse
pressure signal was detected during surgery after graft
deployment. These signals were likely artifactual and due to
external manipulation of the excluded prosthetic aneurysm.
Brisk decay of MAP was detectable only in the Enovus
graft, thus suggesting immediate effective exclusion of the
aneurysm sac from the systemic pressure. The material
properties of the low-permeability ePTFE were likely re-
sponsible for the rapid elimination of sac pressure. The
Enovus and AneuRx devices demonstrated equally effective
long-term MAP elimination during the 30-day postopera-
tive evaluation.
The exponential pressure decay with the Enovus
stent graft is striking but may be dependent or codepen-
dent on the prosthetic aneurysm sac itself. The mainte-
nance of sac pressure after exclusion is dependent on the
materials that comprise the boundaries of the aneurysm
sac. In this experiment, the stent graft and the prosthetic
aneurysm provide those boundaries. The relative contri-
bution of each of these materials to the profile of pressure
dissipation is unknown. However, because the material
properties of the prosthetic AAA remain constant among
Fig 8. Photomicrographs of aneurysm sac contents wer
stent graft. A,Hematoxylin and eosin (original magnific
with rare fibrillar material (F). B, Masson trichrome stai
mature collagen deposition within the field.all three groups, the gradual decay of pressure detectedin aneurysms excluded with the AneuRx and original
Excluder stent grafts suggests that the difference be-
tween the grafts is related to the permeability of the stent
graft material. The histologic differences in the aneurys-
mal sac clot burden further support this hypothesis.
Histologic evidence of chronic and acute thrombus
within the AAAs excluded by the AneuRx and Excluder
grafts suggests ongoing perfusion and continued remod-
eling of the sac thrombus. The absence of thrombus in
the Enovus group of animals suggests the immediate
exclusion of the AAA after graft deployment, with no
further AAA sac perfusion. With completion angiograms
that rule out the presence of endoleaks, it is reasonable to
conclude that the Enovus stent graft markedly reduces
the transudation of permeable serum components, thus
producing a favorable pressure decay curve and effec-
tively eliminating endotension.
CONCLUSION
AAA exclusion with the Enovus stent graft resulted in a
rapid and nearly complete elimination of intra-aneurysmal
pressure in our model. The immediate elimination of pulse
pressure with prompt decay of sac pressure, the low 30-day
pressure measurement profile, and the paucity of fibrin clot
within the excluded aneurysm sac support the hypothesis
that the low-permeability ePTFE Enovus stent graft signif-
icantly inhibits the transudation of fluid and soluble serum
components into the AAA sac. Ultimately, translation to
clinical trials is needed to demonstrate the efficacy of low-
permeability ePTFE stent grafts in preventing the develop-
ment of endotension, aneurysm sac enlargement, and in-
creased rupture risk after EVAR.
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